Where does Cardiovascular Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cardiovascular Systems, Inc. ranks #4,551 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cardiovascular Systems, Inc. hold?

Cardiovascular Systems, Inc. holds 77 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Cardiovascular Systems, Inc.'s Innovation Score?

Cardiovascular Systems, Inc. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cardiovascular Systems, Inc. focus on?

Cardiovascular Systems, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 55 patents, ranking #346 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Cardiovascular Systems, Inc.'s patent grant rate increasing or decreasing?

Cardiovascular Systems, Inc.'s recent grant velocity is -31% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cardiovascular Systems, Inc.'s patents?

Cardiovascular Systems, Inc.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cardiovascular Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cardiovascular Systems, Inc.

USPTO PatentsView assignee record - 77 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardiovascular ranks #4,551 of 49,997 tracked US assignees by granted-patent volume, with 77 patents across 11 technology areas.

#4,551
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 15.2
avg claims per patent: -31%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4551 · US Corporation #4,551 · 77 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 77 grants
TOP-DECILE #4,551/49,997
PHOTO-FINISH Berlin Heart
CPC-FOCUS A61B · 11 areas
INNOV-PAR 40.6/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -31% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Berlin Heart GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cardiovascular’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.0 pts (37%) Velocity 4.7 pts (12%) Breadth 11.7 pts (29%) Claim depth 9.1 pts (22%)

Qualcomm Incorporated · highest

85
Cardiovascular Systems · this assignee

41
France Telecom · near

41
Orthofix S R L · near

41
Pixart Imaging… · near

41
Takata · near

41
3D Lighting… · lowest

7

What this shows Cardiovascular's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cardiovascular?

Each dot is one of Cardiovascular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardiovascular’s own 15.2 claims/patent is at or below the 17.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cardiovascular vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cardiovascular's grants concentrate

Cardiovascular Systems, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 71.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (16 grants) versus a trough of 2 in 2023. By volume, Cardiovascular sits between Berlin Heart GmbH and Emulate, Inc..

Cardiovascular's three-year grant acceleration

From 2019–2021 to 2022–2024, Cardiovascular Systems, Inc. moved from 20 to 14 grants (0.70x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Berlin Heart

77
Chep Technology P…

77
Crispr Therapeuti…

77
Camso

77
Credo Technology…

77
Dong-eui Universi…

77
Dril-quip

77
Emulate

77
Cardiovascular Sy… ◀

77

What this shows Cardiovascular holds 77 patents at rank #4,553, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardiovascular

By rank, the assignees closest to #4,553 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Cardiovascular's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardiovascular, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Cardiovascular ranks #346 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

France Telecom 41 Takata Corporation 41 Orthofix S.R.L. 41 Pixart Imaging (PENANG) SDN. BHD. 41

Similar claim depth

Nearest assignees by average claims per patent (15.2 here).

Universitat Zurich 15.2 avg Institut Curie 15.2 avg Newfrey LLC 15.2 avg Outotec (FINLAND) OY 15.2 avg

Cardiovascular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cardiovascular Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	16	20.8%
2016	5	6.5%
2017	8	10.4%
2018	8	10.4%
2019	5	6.5%
2020	6	7.8%
2021	9	11.7%
2022	7	9.1%
2023	2	2.6%
2024	5	6.5%
2025partial year	6	7.8%

Which technologies does Cardiovascular Systems, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 55

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 27

Y10T - Technical Subjects Covered BY Former US Classification 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

F16D - Couplings FOR Transmitting ROTATION; CLUTCHES; Brakes 1

H04B - Transmission 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cardiovascular Systems, Inc.'s patent record in context - here's where to go next.

Cardiovascular Systems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 71.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #4,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cardiovascular Systems, Inc. against Berlin Heart GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.